SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

04 Feb 2026 Evaluate
The sales slipped to Rs. 396.80 millions, down -59.11% for the December 2025 quarter as against Rs. 970.40 millions during the year-ago period.The Net Loss for the quarter ended December 2025 is Rs. -231.30 millions as compared to Net Loss of Rs. -132.80 millions of corresponding quarter ended December 2024The company reported a degrowth in operating Profit to 36.00 millions from 149.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 396.80 970.40 -59.11 1628.40 2937.40 -44.56 3998.40 3273.50 22.14
Other Income 71.00 -80.10 -188.64 556.90 275.10 102.44 329.80 630.50 -47.69
PBIDT 36.00 149.50 -75.92 600.30 787.70 -23.79 1047.70 698.50 49.99
Interest 235.10 177.70 32.30 643.80 490.90 31.15 704.00 681.90 3.24
PBDT -199.10 -28.20 606.03 -43.50 296.80 -114.66 343.70 -13.90 -2572.66
Depreciation 151.60 164.80 -8.01 474.20 491.00 -3.42 652.00 1016.10 -35.83
PBT -350.70 -193.00 81.71 -517.70 -194.20 166.58 -308.30 -1030.00 -70.07
TAX -119.40 -60.20 98.34 -177.10 -169.20 4.67 -209.60 -265.90 -21.17
Deferred Tax -119.40 -60.20 98.34 -177.10 -169.20 4.67 -209.60 -376.50 -44.33
PAT -231.30 -132.80 74.17 -340.60 -25.00 1262.40 -98.70 -764.10 -87.08
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 31360.00 -99.00
PBIDTM(%) 9.07 15.41 -41.11 36.86 26.82 37.47 26.20 21.34 22.80

Dishman Carbogen Amc Share Price

184.45 7.60 (4.30%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: